Tuesday, July 22, 2025
LBNN
  • Business
  • Markets
  • Politics
  • Crypto
  • Finance
  • Energy
  • Technology
  • Taxes
  • Creator Economy
  • Wealth Management
  • Documentaries
No Result
View All Result
LBNN

Intrinsic Therapeutics, Inc. Announces Positive Coverage Policy by Cigna Healthcare for Barricaid Bone-Anchored Annular Closure Device

Simon Osuji by Simon Osuji
June 22, 2023
in Technology
0
Intrinsic Therapeutics, Inc. Announces Positive Coverage Policy by Cigna Healthcare for Barricaid Bone-Anchored Annular Closure Device
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

BOSTON, June 21, 2023 /PRNewswire/ –Intrinsic Therapeutics Inc., a medical device company focused on preventing reherniation and reoperation following lumbar discectomy, announced today that Cigna Healthcare has issued a positive coverage policy for the Barricaid® Bone-Anchored Annular Closure device. Cigna Healthcare represents one of the five largest commercial payors in the US, with an estimated nineteen million covered lives.

Related posts

Gene therapy faces fresh uncertainty as two more top FDA officials depart

FDA panel elevates concerns over antidepressant use during pregnancy

July 22, 2025
AGESI, UNDP deepen partnership for a sustainable Nigeria – EnviroNews

AGESI, UNDP deepen partnership for a sustainable Nigeria – EnviroNews

July 22, 2025


Barricaid is a proprietary technology designed to prevent reherniation and reoperation in patients with large annular defects following lumbar discectomy surgery


“I applaud Cigna’s rigorous review of Barricaid and their decision to issue this positive policy.” – Betsy Grunch MD


Intrinsic Therapeutics founder Greg Lambrecht stated, “Twenty years ago I set out to find a solution to save others from the heartbreak I witnessed with my mother’s failed spinal operations. This new coverage policy will give Cigna members access to the Barricaid technology and help to reduce the burden of reherniation and reoperation for discectomy patients when deemed medically necessary by their surgeon.”


Betsy Grunch MD, FAANS, FACS, a board-certified neurosurgeon at The Longstreet Clinic in Gainesville, Georgia, said of the policy, “This is the culmination of years of clinical research and the publication of compelling clinical evidence supporting Barricaid’s efficacy. Now I can offer my patients with large annular defects a treatment to avoid problems with reherniations. I applaud Cigna’s rigorous clinical review and their decision to issue this positive policy. I expect other payors to update and cover Barricaid following the recent publication of additional data.”


Cigna Healthcare’s expanded coverage policy went into effect on June 15, 2023, and will enable discectomy patients with large annular defects access to Barricaid, which is indicated to reduce reherniation and reoperations in this patient population.


About Intrinsic Therapeutics

Barricaid is a proprietary technology designed to prevent reherniation and reoperation in patients with large annular defects following lumbar discectomy surgery.  Barricaid has been implanted in more than ten thousand patients and is supported by clinical studies in 8 distinct patient populations, including two randomized controlled trials and six single armed trials. A multicenter level I RCT demonstrating superior outcomes to discectomy alone with 5-year results was published in JAMA.


In 2019, Barricaid received FDA Pre-Market Approval, in 2020 Centers for Medicare and Medicaid Services (CMS) issued a C-code for hospitals and surgery centers to report for billing and payment, and in late 2022 the Centers for Disease Control (CDC) issued ICD-10 codes to track and monitor defect size in discectomy patients. 


For full benefit-risk information, please visit www.Barricaid.com 


Media Contact:

Jake Tanner, VP of Marketing

760-525-9739

jtanner@barricaid.com


Barricaid is a registered trademark of Intrinsic Therapeutics, Inc.


Barricaid is a proprietary technology designed to prevent reherniation and reoperation in patients with large annular defects following lumbar discectomy surgery


Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/intrinsic-therapeutics-inc-announces-positive-coverage-policy-by-cigna-healthcare-for-barricaid-bone-anchored-annular-closure-device-301856526.html


SOURCE Intrinsic Therapeutics, Inc.

Source link

Previous Post

How can Nigeria build on the payment evolution brought about by the Naira shortage

Next Post

Why I severed ties with my mother – Yvonne Nelson

Next Post
Why I severed ties with my mother – Yvonne Nelson

Why I severed ties with my mother - Yvonne Nelson

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED NEWS

This week in AI: Microsoft’s sticks an AI ad on keyboards

This week in AI: Microsoft’s sticks an AI ad on keyboards

2 years ago
Women’s wing of Modi’s party calls for probe into Foxconn India hiring practices

Women’s wing of Modi’s party calls for probe into Foxconn India hiring practices

1 year ago
1121 Job Openings Available for NYS Graduates in Australia

1121 Job Openings Available for NYS Graduates in Australia

11 months ago

Vertex and Lonza to Build Dedicated Manufacturing Facility for Type 1 Diabetes (T1D) Cell Therapies

2 years ago

POPULAR NEWS

  • Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

    Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

    0 shares
    Share 0 Tweet 0
  • When Will SHIB Reach $1? Here’s What ChatGPT Says

    0 shares
    Share 0 Tweet 0
  • The world’s top 10 most valuable car brands in 2025

    0 shares
    Share 0 Tweet 0
  • Top 10 African countries with the highest GDP per capita in 2025

    0 shares
    Share 0 Tweet 0
  • Tanzania’s natural gas sector goes global with Dubai deal

    0 shares
    Share 0 Tweet 0
  • Privacy Policy
  • Contact

© 2023 LBNN - All rights reserved.

No Result
View All Result
  • Home
  • Business
  • Politics
  • Markets
  • Crypto
  • Economics
    • Manufacturing
    • Real Estate
    • Infrastructure
  • Finance
  • Energy
  • Creator Economy
  • Wealth Management
  • Taxes
  • Telecoms
  • Military & Defense
  • Careers
  • Technology
  • Artificial Intelligence
  • Investigative journalism
  • Art & Culture
  • Documentaries
  • Quizzes
    • Enneagram quiz
  • Newsletters
    • LBNN Newsletter
    • Divergent Capitalist

© 2023 LBNN - All rights reserved.